» Articles » PMID: 9349951

Low-dose Radiation Therapy for Age-related Macular Degeneration

Overview
Specialty Ophthalmology
Date 1997 Nov 14
PMID 9349951
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The study was carried out to evaluate the effect of low-dose radiation therapy in patients with age-related macular degeneration.

Methods: One hundred eyes of 78 patients (mean age 72 years) with different forms of age-related macular degeneration were treated with external beam radiotherapy between 1971 and 1989. In four fractions a total dose of 2 Gy was administered over 7 days. Radiation therapy was performed by the conventional 200-kV technique. The mean duration of follow-up period was 7 years (range 0.5 to 20 years). A control group was composed of 96 eyes from patients with AMD who received no therapy. The mean visual acuity at first presentation and the duration of follow-up was the same as in the treatment group.

Results: No difference in visual acuity between the treatment and control groups could be observed. After 1, 2, 5 and 10 years the mean visual acuity was equal in the radiation group and the control group. Even in subgroup analysis regarding only the eyes with exudative forms of AMD, no effect of this treatment strategy could be demonstrated.

Conclusion: Our results suggest that low-dose radiation therapy in patients with age-related macular degeneration has no beneficial effect. However, it must be considered that the dose of 2 Gy is low in comparison to doses used in recently published studies (5-24 Gy).

Citing Articles

Radiotherapy for neovascular age-related macular degeneration.

Evans J, Igwe C, Jackson T, Chong V Cochrane Database Syst Rev. 2020; 8:CD004004.

PMID: 32844399 PMC: 8812340. DOI: 10.1002/14651858.CD004004.pub4.


Context for Protons as Adjunctive Therapy in Neovascular Age-Related Macular Degeneration: A Review.

Rice S, Katz M, Mehta M Int J Part Ther. 2019; 2(4):555-569.

PMID: 31772967 PMC: 6871634. DOI: 10.14338/IJPT-15-00019.1.


Radiotherapy for neovascular age-related macular degeneration.

Evans J, Sivagnanavel V, Chong V Cochrane Database Syst Rev. 2010; (5):CD004004.

PMID: 20464726 PMC: 7163277. DOI: 10.1002/14651858.CD004004.pub3.


Radiotherapy for recurrent choroidal neovascularisation complicating age related macular degeneration.

Marcus D, Sheils W, Young J, McIntosh S, Johnson M, Alexander J Br J Ophthalmol. 2003; 88(1):114-9.

PMID: 14693787 PMC: 1771925. DOI: 10.1136/bjo.88.1.114.


A 5-year follow-up study for distance visual acuity after low dose radiation on subfoveal choroidal neovascularization in age-related macular degeneration.

Valmaggia C, Ries G, Ballinari P Doc Ophthalmol. 2002; 103(3):201-9.

PMID: 11824657 DOI: 10.1023/a:1013047722865.

References
1.
Nakissa N, Rubin P, Strohl R, KEYS H . Ocular and orbital complications following radiation therapy of paranasal sinus malignancies and review of literature. Cancer. 1983; 51(6):980-6. DOI: 10.1002/1097-0142(19830315)51:6<980::aid-cncr2820510603>3.0.co;2-y. View

2.
COGAN D . Lesions of the eye from radiant energy. J Am Med Assoc. 1950; 142(3):145-51. DOI: 10.1001/jama.1950.02910210001001. View

3.
Valmaggia C, Bischoff P, Ries G . [Low dosage radiotherapy of subfoveal neovascularization in age-related macular degeneration. Preliminary results]. Klin Monbl Augenheilkd. 1995; 206(5):343-6. DOI: 10.1055/s-2008-1035458. View

4.
SAUTTER H, UTERMANN D . [PSEUDOTUMOR OF THE MACULA]. Klin Monbl Augenheilkd. 1964; 145:1-18. View

5.
. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol. 1991; 109(9):1220-31. DOI: 10.1001/archopht.1991.01080090044025. View